A secreted form of chorismate mutase (Rv1885c) in Mycobacterium bovis BCG contributes to pathogenesis by inhibiting mitochondria-mediated apoptotic cell death of macrophages.
Deletion mutant
Intrinsic apoptosis
M. bovis BCG
M. tuberculosis
Macrophages
Mitochondrial dysfunction
Mycobacterium tuberculosis chorismate mutase (TBCM)
Rv1885c
Virulence factor
Journal
Journal of biomedical science
ISSN: 1423-0127
Titre abrégé: J Biomed Sci
Pays: England
ID NLM: 9421567
Informations de publication
Date de publication:
18 Dec 2023
18 Dec 2023
Historique:
received:
30
08
2023
accepted:
12
12
2023
medline:
19
12
2023
pubmed:
19
12
2023
entrez:
19
12
2023
Statut:
epublish
Résumé
Mycobacterium tuberculosis is the causative agent of tuberculosis (TB), and its pathogenicity is associated with its ability to evade the host defense system. The secretory form of the chorismate mutase of M. tuberculosis (TBCM, encoded by Rv1885c) is assumed to play a key role in the pathogenesis of TB; however, the mechanism remains unknown. A tbcm deletion mutant (B∆tbcm) was generated by targeted gene knockout in BCG to investigate the pathogenic role of TBCM in mice or macrophages. We compared the pathogenesis of B∆tbcm and wild-type BCG in vivo by measuring the bacterial clearance rate and the degree of apoptosis. Promotion of the intrinsic apoptotic pathway was evaluated in infected bone marrow-derived macrophages (BMDMs) by measuring apoptotic cell death, loss of mitochondrial membrane potential and translocation of pore-forming proteins. Immunocytochemistry, western blotting and real-time PCR were also performed to assess the related protein expression levels after infection. Furthermore, these findings were validated by complementation of tbcm in BCG. Deletion of the tbcm gene in BCG leads to reduced pathogenesis in a mouse model, compared to wild type BCG, by promoting apoptotic cell death and bacterial clearance. Based on these findings, we found that intrinsic apoptosis and mitochondrial impairment were promoted in B∆tbcm-infected BMDMs. B∆tbcm down-regulates the expression of Bcl-2, which leads to mitochondrial outer membrane permeabilization (MOMP), culminating in cytochrome c release from mitochondria. Consistent with this, transcriptome profiling also indicated that B∆tbcm infection is more closely related to altered mitochondrial-related gene expression than wild-type BCG infection, suggesting an inhibitory role of TBCM in mitochondrial dysfunction. Moreover, genetic complementation of B∆tbcm (C∆tbcm) restored its capacity to inhibit mitochondria-mediated apoptotic cell death. Our findings demonstrate the contribution of TBCM to bacterial survival, inhibiting intrinsic apoptotic cell death of macrophages as a virulence factor of M. tuberculosis complex (MTBC) strains, which could be a potential target for the development of TB therapy.
Sections du résumé
BACKGROUND
BACKGROUND
Mycobacterium tuberculosis is the causative agent of tuberculosis (TB), and its pathogenicity is associated with its ability to evade the host defense system. The secretory form of the chorismate mutase of M. tuberculosis (TBCM, encoded by Rv1885c) is assumed to play a key role in the pathogenesis of TB; however, the mechanism remains unknown.
METHODS
METHODS
A tbcm deletion mutant (B∆tbcm) was generated by targeted gene knockout in BCG to investigate the pathogenic role of TBCM in mice or macrophages. We compared the pathogenesis of B∆tbcm and wild-type BCG in vivo by measuring the bacterial clearance rate and the degree of apoptosis. Promotion of the intrinsic apoptotic pathway was evaluated in infected bone marrow-derived macrophages (BMDMs) by measuring apoptotic cell death, loss of mitochondrial membrane potential and translocation of pore-forming proteins. Immunocytochemistry, western blotting and real-time PCR were also performed to assess the related protein expression levels after infection. Furthermore, these findings were validated by complementation of tbcm in BCG.
RESULTS
RESULTS
Deletion of the tbcm gene in BCG leads to reduced pathogenesis in a mouse model, compared to wild type BCG, by promoting apoptotic cell death and bacterial clearance. Based on these findings, we found that intrinsic apoptosis and mitochondrial impairment were promoted in B∆tbcm-infected BMDMs. B∆tbcm down-regulates the expression of Bcl-2, which leads to mitochondrial outer membrane permeabilization (MOMP), culminating in cytochrome c release from mitochondria. Consistent with this, transcriptome profiling also indicated that B∆tbcm infection is more closely related to altered mitochondrial-related gene expression than wild-type BCG infection, suggesting an inhibitory role of TBCM in mitochondrial dysfunction. Moreover, genetic complementation of B∆tbcm (C∆tbcm) restored its capacity to inhibit mitochondria-mediated apoptotic cell death.
CONCLUSIONS
CONCLUSIONS
Our findings demonstrate the contribution of TBCM to bacterial survival, inhibiting intrinsic apoptotic cell death of macrophages as a virulence factor of M. tuberculosis complex (MTBC) strains, which could be a potential target for the development of TB therapy.
Identifiants
pubmed: 38110948
doi: 10.1186/s12929-023-00988-2
pii: 10.1186/s12929-023-00988-2
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
95Subventions
Organisme : Ministry of Health and Welfare
ID : HI22C0312
Informations de copyright
© 2023. The Author(s).
Références
MacNeil A, Glaziou P, Sismanidis C, Date A, Maloney S, Floyd K. Global epidemiology of tuberculosis and progress toward meeting global targets—worldwide, 2018. Morb Mortal Wkly Rep. 2020;69(11):281.
doi: 10.15585/mmwr.mm6911a2
Cernuschi T, Malvolti S, Nickels E, Friede M. Bacillus Calmette-Guérin (BCG) vaccine: a global assessment of demand and supply balance. Vaccine. 2018;36(4):498–506.
pubmed: 29254839
pmcid: 5777639
doi: 10.1016/j.vaccine.2017.12.010
Shahmohammadi S, Saffar MJ, Rezai MS. BCG-osis after BCG vaccination in immunocompromised children: Case series and review. J Pediatr Rev. 2014;2(1):62–74.
Behar S, Martin C, Booty M, Nishimura T, Zhao X, Gan H, et al. Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis. Mucosal Immunol. 2011;4(3):279–87.
pubmed: 21307848
pmcid: 3155700
doi: 10.1038/mi.2011.3
Weiss G, Schaible UE. Macrophage defense mechanisms against intracellular bacteria. Immunol Rev. 2015;264(1):182–203.
pubmed: 25703560
pmcid: 4368383
doi: 10.1111/imr.12266
Miller JL, Velmurugan K, Cowan MJ, Briken V. The type I NADH dehydrogenase of Mycobacterium tuberculosis counters phagosomal NOX2 activity to inhibit TNF-α-mediated host cell apoptosis. PLoS Pathog. 2010;6(4): e1000864.
pubmed: 20421951
pmcid: 2858756
doi: 10.1371/journal.ppat.1000864
Light SH, Halavaty AS, Minasov G, Shuvalova L, Anderson WF. Structural analysis of a 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase with an N-terminal chorismate mutase-like regulatory domain. Protein Sci. 2012;21(6):887–95.
pubmed: 22505283
pmcid: 3403423
doi: 10.1002/pro.2075
Agrawal H, Kumar A, Bal NC, Siddiqi MI, Arora A. Ligand based virtual screening and biological evaluation of inhibitors of chorismate mutase (Rv1885c) from Mycobacterium tuberculosis H37Rv. Bioorg Med Chem Lett. 2007;17(11):3053–8.
pubmed: 17418569
doi: 10.1016/j.bmcl.2007.03.053
Kim S-K, Reddy SK, Nelson BC, Vasquez GB, Davis A, Howard AJ, et al. Biochemical and structural characterization of the secreted chorismate mutase (Rv1885c) from Mycobacterium tuberculosis H37Rv: an* AroQ enzyme not regulated by the aromatic amino acids. J Bacteriol. 2006;188(24):8638–48.
pubmed: 17146044
pmcid: 1698256
doi: 10.1128/JB.00441-06
Khanapur M, Alvala M, Prabhakar M, Kumar KS, Edwin R, Saranya PS, et al. Mycobacterium tuberculosis chorismate mutase: a potential target for TB. Bioorg Med Chem. 2017;25(6):1725–36.
pubmed: 28202315
doi: 10.1016/j.bmc.2017.02.001
Jeong H, Lee S-Y, Seo H, Kim DH, Lee D, Kim B-J. Potential of Mycobacterium tuberculosis chorismate mutase (Rv1885c) as a novel TLR4-mediated adjuvant for dendritic cell-based cancer immunotherapy. Oncoimmunology. 2022;11(1):2023340.
pubmed: 35083095
pmcid: 8786331
doi: 10.1080/2162402X.2021.2023340
Gopinath K, Warner DF, Mizrahi V. Targeted gene knockout and essentiality testing by homologous recombination. Mycobacteria Protocols. 2015:131–49.
Aberdein J, Cole J, Bewley M, Marriott H, Dockrell D. Alveolar macrophages in pulmonary host defence—the unrecognized role of apoptosis as a mechanism of intracellular bacterial killing. Clin Exp Immunol. 2013;174(2):193–202.
pubmed: 23841514
pmcid: 3828822
doi: 10.1111/cei.12170
Kraupp BG, Ruttkay-Nedecky B, Koudelka H, Bukowska K, Bursch W, Schulte-Hermann R. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology. 1995;21(5):1465–8.
doi: 10.1002/hep.1840210534
Cavalcanti YVN, Brelaz MCA, Neves JKdAL, Ferraz JC, Pereira VRA. Role of TNF-alpha, IFN-gamma, and IL-10 in the development of pulmonary tuberculosis. Pulm Med. 2012;2012.
Rubins JB. Alveolar macrophages: wielding the double-edged sword of inflammation. American Thoracic Society; 2003. p. 103–4.
Span L, Pennings A, Vierwinden G, Boezeman J, Raymakers R, De Witte T. The dynamic process of apoptosis analyzed by flow cytometry using Annexin‐V/propidium iodide and a modified in situ end labeling technique. Cytometry: The Journal of the International Society for Analytical Cytology. 2002;47(1):24–31.
Lee J, Hartman M, Kornfeld H. Macrophage apoptosis in tuberculosis. Yonsei Med J. 2009;50(1):1–11.
pubmed: 19259342
pmcid: 2649858
doi: 10.3349/ymj.2009.50.1.1
Hussar P. Apoptosis regulators bcl-2 and caspase-3. Encyclopedia. 2022;2(4):1624–36.
doi: 10.3390/encyclopedia2040111
Ola MS, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol Cell Biochem. 2011;351:41–58.
pubmed: 21210296
doi: 10.1007/s11010-010-0709-x
Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 1997;91(4):479–89.
pubmed: 9390557
doi: 10.1016/S0092-8674(00)80434-1
Arnett E, Schlesinger LS. Live and let die: TB control by enhancing apoptosis. Immunity. 2021;54(8):1625–7.
pubmed: 34380059
doi: 10.1016/j.immuni.2021.07.010
Avrutsky MI, Troy CM. Caspase-9: a multimodal therapeutic target with diverse cellular expression in human disease. Front Pharmacol. 2021;12: 701301.
pubmed: 34305609
pmcid: 8299054
doi: 10.3389/fphar.2021.701301
Huang N-J, Zhang L, Tang W, Chen C, Yang C-S, Kornbluth S. The Trim39 ubiquitin ligase inhibits APC/CCdh1-mediated degradation of the Bax activator MOAP-1. J Cell Biol. 2012;197(3):361–7.
pubmed: 22529100
pmcid: 3341153
doi: 10.1083/jcb.201111141
San Lee S, Fu NY, Sukumaran SK, Wan KF, Wan Q, Victor CY. TRIM39 is a MOAP-1-binding protein that stabilizes MOAP-1 through inhibition of its poly-ubiquitination process. Exp Cell Res. 2009;315(7):1313–25.
pubmed: 19100260
doi: 10.1016/j.yexcr.2008.11.021
Summers DW, DiAntonio A, Milbrandt J. Mitochondrial dysfunction induces Sarm1-dependent cell death in sensory neurons. J Neurosci. 2014;34(28):9338–50.
pubmed: 25009267
pmcid: 4087211
doi: 10.1523/JNEUROSCI.0877-14.2014
Kishita Y, Pajak A, Bolar NA, Marobbio CM, Maffezzini C, Miniero DV, et al. Intra-mitochondrial methylation deficiency due to mutations in SLC25A26. Am J Hum Genet. 2015;97(5):761–8.
pubmed: 26522469
pmcid: 4667130
doi: 10.1016/j.ajhg.2015.09.013
Yatsuka Y, Kishita Y, Formosa LE, Shimura M, Nozaki F, Fujii T, et al. A homozygous variant in NDUFA8 is associated with developmental delay, microcephaly, and epilepsy due to mitochondrial complex I deficiency. Clin Genet. 2020;98(2):155–65.
pubmed: 32385911
doi: 10.1111/cge.13773
Lam C-w, Yeung W-L, Ling T-k, Wong K-c, Law C-y. Deoxythymidylate kinase, DTYMK, is a novel gene for mitochondrial DNA depletion syndrome. Clinica Chimica Acta. 2019;496:93–9.
Ly JD, Grubb DR, Lawen A. The mitochondrial membrane potential (Δψ m) in apoptosis; an update. Apoptosis. 2003;8:115–28.
pubmed: 12766472
doi: 10.1023/A:1022945107762
Scaduto RC, Grotyohann LW. Measurement of mitochondrial membrane potential using fluorescent rhodamine derivatives. Biophys J. 1999;76(1):469–77.
pubmed: 9876159
pmcid: 1302536
doi: 10.1016/S0006-3495(99)77214-0
Smiley ST, Reers M, Mottola-Hartshorn C, Lin M, Chen A, Smith TW, et al. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc Natl Acad Sci. 1991;88(9):3671–5.
pubmed: 2023917
pmcid: 51514
doi: 10.1073/pnas.88.9.3671
Dunn JD, Alvarez LA, Zhang X, Soldati T. Reactive oxygen species and mitochondria: a nexus of cellular homeostasis. Redox Biol. 2015;6:472–85.
doi: 10.1016/j.redox.2015.09.005
Naik E, Dixit VM. Mitochondrial reactive oxygen species drive proinflammatory cytokine production. J Exp Med. 2011;208(3):417–20.
pubmed: 21357740
pmcid: 3058577
doi: 10.1084/jem.20110367
Weindel CG, Martinez EL, Zhao X, Mabry CJ, Bell SL, Vail KJ, et al. Mitochondrial ROS promotes susceptibility to infection via gasdermin D-mediated necroptosis. Cell. 2022;185(17):3214-31 e23.
pubmed: 35907404
pmcid: 9531054
doi: 10.1016/j.cell.2022.06.038
Peña-Blanco A, García-Sáez AJ. Bax, Bak and beyond—mitochondrial performance in apoptosis. FEBS J. 2018;285(3):416–31.
pubmed: 28755482
doi: 10.1111/febs.14186
Liang JR, Martinez A, Lane JD, Mayor U, Clague MJ, Urbé S. USP 30 deubiquitylates mitochondrial P arkin substrates and restricts apoptotic cell death. EMBO Rep. 2015;16(5):618–27.
pubmed: 25739811
pmcid: 4428036
doi: 10.15252/embr.201439820
Lee H, Kim B-J, Kim B-R, Kook Y-H, Kim B-J. The development of a novel Mycobacterium-Escherichia coli shuttle vector system using pMyong2, a linear plasmid from Mycobacterium yongonense DSM 45126T. PLoS ONE. 2015;10(3): e0122897.
pubmed: 25822634
pmcid: 4378964
doi: 10.1371/journal.pone.0122897
Schneider CZ, Parish T, Basso LA, Santos DS. The two chorismate mutases from both Mycobacterium tuberculosis and Mycobacterium smegmatis: biochemical analysis and limited regulation of promoter activity by aromatic amino acids. J Bacteriol. 2008;190(1):122–34.
pubmed: 17965159
doi: 10.1128/JB.01332-07
Hoffmann R, Jonker M, Brandenburg S, De Bruin H, Ten Hacken N, Van Oosterhout A, et al. Mitochondrial dysfunction increases pro-inflammatory cytokine production and impairs repair and corticosteroid responsiveness in lung epithelium. Sci Rep. 2019;9(1):15047.
pubmed: 31636329
pmcid: 6803636
doi: 10.1038/s41598-019-51517-x
López-Armada MJ, Riveiro-Naveira RR, Vaamonde-García C, Valcárcel-Ares MN. Mitochondrial dysfunction and the inflammatory response. Mitochondrion. 2013;13(2):106–18.
pubmed: 23333405
doi: 10.1016/j.mito.2013.01.003
Couper KN, Blount DG, Riley EM. IL-10: the master regulator of immunity to infection. J Immunol. 2008;180(9):5771–7.
pubmed: 18424693
doi: 10.4049/jimmunol.180.9.5771
Fallahi-Sichani M, Flynn JL, Linderman JJ, Kirschner DE. Differential risk of tuberculosis reactivation among anti-TNF therapies is due to drug binding kinetics and permeability. J Immunol. 2012;188(7):3169–78.
pubmed: 22379032
doi: 10.4049/jimmunol.1103298
Qamra R, Prakash P, Aruna B, Hasnain SE, Mande SC. The 2.15 Å crystal structure of Mycobacterium tuberculosis chorismate mutase reveals an unexpected gene duplication and suggests a role in host− pathogen interactions. Biochemistry. 2006;45(23):6997–7005.
pubmed: 16752890
doi: 10.1021/bi0606445
Dockrell HM, Smith SG. What have we learnt about BCG vaccination in the last 20 years? Front Immunol. 2017;8:1134.
pubmed: 28955344
pmcid: 5601272
doi: 10.3389/fimmu.2017.01134
da Costa AC, Nogueira SV, Kipnis A, Junqueira-Kipnis AP. Recombinant BCG: innovations on an old vaccine. Scope of BCG strains and strategies to improve long-lasting memory. Front Immunol. 2014;5:152.
pubmed: 24778634
pmcid: 3984997
doi: 10.3389/fimmu.2014.00152